<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Virus Security Free Code Script</title><link>http://www.bing.com:80/search?q=Virus+Security+Free+Code+Script</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Virus Security Free Code Script</title><link>http://www.bing.com:80/search?q=Virus+Security+Free+Code+Script</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Coronavirus - World Health Organization (WHO)</title><link>https://www.who.int/health-topics/coronavirus</link><description>Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention.</description><pubDate>Sun, 19 Apr 2026 23:19:00 GMT</pubDate></item><item><title>Virus respiratorio sincitial (VRS)</title><link>https://www.who.int/es/news-room/fact-sheets/detail/respiratory-syncytial-virus-(rsv)</link><description>El virus respiratorio sincitial (VRS) es una de las causas más comunes de infección aguda de las vías respiratorias inferiores en niños en todo el mundo, además de provocar una carga sustancial de enfermedad respiratoria grave en las personas mayores.</description><pubDate>Tue, 21 Apr 2026 18:16:00 GMT</pubDate></item><item><title>WHO prequalifies first maternal respiratory syncytial virus vaccine</title><link>https://www.who.int/news/item/19-03-2025-who-prequalifies-first-maternal-respiratory-syncytial-virus-vaccine</link><description>On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants against one of the most common causes of acute lower respiratory infections in children globally.</description><pubDate>Sat, 18 Apr 2026 23:20:00 GMT</pubDate></item><item><title>Nipah Virus Infection - India - World Health Organization (WHO)</title><link>https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON577</link><description>Between 17 May and 12 July 2025, the Information and Public Relations Department, Government of Kerala informed through a series of official press releases about four confirmed cases, including two deaths, due to Nipah virus (NiV) infection in two districts of Kerala State. NiV infection is a bat-borne disease transmitted to humans through infected animals (such as bats or pigs), contaminated ...</description><pubDate>Sat, 25 Apr 2026 02:05:00 GMT</pubDate></item><item><title>Enfermedad por el virus del Oropuche - World Health Organization (WHO)</title><link>https://www.who.int/es/news-room/fact-sheets/detail/oropouche-virus-disease</link><description>La enfermedad por el virus del Oropuche está causada por una infección vírica que puede causar fiebre, cefalea, dolores articulares y musculares, escalofríos, náuseas, vómitos y exantemas. La mayoría de los infectados se recuperan espontáneamente, pero algunos presentan síntomas graves.</description><pubDate>Tue, 21 Apr 2026 09:05:00 GMT</pubDate></item><item><title>Ebola virus disease - Democratic Republic of the Congo</title><link>https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON580</link><description>Ebola virus disease is a serious, often fatal illness in humans. The virus is transmitted to humans through close contact with the blood or secretions of infected wildlife and then spreads through human-to-human transmission.</description><pubDate>Fri, 24 Apr 2026 14:02:00 GMT</pubDate></item><item><title>WHO Consultation on the Composition of Influenza Virus Vaccines for Use ...</title><link>https://www.who.int/news-room/events/detail/2025/09/22/default-calendar/who-consultation-on-the-composition-of-influenza-virus-vaccines-for-use-in-the-2026-southern-hemisphere-influenza-season</link><description>Recommendations for the composition of influenza virus vaccines for use in the 2026 Southern Hemisphere influenza season; and Review of the need and subsequent selection of new A (H5) and other subtypes or variant viruses for the development of new candidate vaccine viruses for pandemic preparedness purposes.</description><pubDate>Fri, 17 Apr 2026 03:19:00 GMT</pubDate></item><item><title>Recommended composition of influenza virus vaccines for use in the 2026 ...</title><link>https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2026-2027-northern-hemisphere-influenza-season</link><description>Frequently Asked Questions - Recommended composition of influenza virus vaccines Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness in the 2026-2027 northern hemisphere influenza season</description><pubDate>Sun, 19 Apr 2026 11:09:00 GMT</pubDate></item><item><title>Coronavirus disease (COVID-19)</title><link>https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-%28covid-19%29</link><description>Ongoing activities in this respect include regular issuance of Disease Outbreak News posts, supporting ongoing research, updating guidance, monitoring virus trends, and evaluating vaccine composition. To guide this shift, WHO has developed a strategic and operational plan to help countries manage COVID-19 as part of routine health systems.</description><pubDate>Thu, 23 Apr 2026 22:39:00 GMT</pubDate></item><item><title>Recommendations announced for influenza vaccine composition for the ...</title><link>https://www.who.int/news/item/26-09-2025-recommendations-announced-for-influenza-vaccine-composition-for-the-2026-southern-hemisphere-influenza-season</link><description>The World Health Organization (WHO) today announced its recommendations for the viral composition of influenza vaccines for use in the 2026 influenza season in the southern hemisphere. The announcement was made at an Information Meeting after a 4-day Consultation on the Composition of Influenza Virus Vaccines.</description><pubDate>Sun, 05 Apr 2026 14:10:00 GMT</pubDate></item></channel></rss>